Literature DB >> 26110283

Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma.

Jessica N Williams1, Jean L Koff2, Christopher R Flowers2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26110283      PMCID： PMC4592391          DOI： 10.1002/cncr.29508

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients.

Authors:  Oreofe O Odejide; Angel M Cronin; Amy J Davidoff; Ann S LaCasce; Gregory A Abel
Journal:  Leuk Lymphoma       Date:  2014-08-06

2.  Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma.

Authors:  Christine C Davis; Jonathon B Cohen; Katherine S Shah; Don A Hutcherson; Minal J Surati; Kelly Valla; Elyse H Panjic; Caitlin E Handler; Jeffrey M Switchenko; Christopher R Flowers
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-12-31

3.  Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.

Authors:  Jessica N Williams; Ashish Rai; Joseph Lipscomb; Jean L Koff; Loretta J Nastoupil; Christopher R Flowers
Journal:  Cancer       Date:  2015-02-11       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.